Posts filed under: Cardiac Surgery

Register to receive a free Cardiac Surgery and Heart Valve Devices Market Report Suite for US 2018-2024 synopsis and brochure Edwards Lifesciences has won the latest round in a series of disputes with Boston Scientific over transcatheter aortic valve replacement (TAVR) patents. Irvine,...
Continue Reading →
Register to receive a free Cardiac Surgery and Heart Valve Devices Market Report Suite for US 2018-2024 synopsis and brochure A new cardiac surgical procedure to treat mitral valve disease, which is minimally invasive, does not require open-heart surgery, and offers faster...
Continue Reading →
Register to receive a free Cardiac Surgery and Heart Valve Devices Market Report Suite for US 2018-2024 synopsis and brochure Dextera Surgical Inc., a company developing and commercializing the MicroCutter 5/80™ Stapler, today announced that it had obtained approval by the Bankruptcy...
Continue Reading →
Register to receive a free Cardiac Surgery and Heart Valve Devices Market Report Suite for US 2018-2024 synopsis and brochure Boston Scientific announced it agreed to buy a stake in Millipede Inc., which has developed a transcatheter-based treatment for severe mitral regurgitation,...
Continue Reading →
Approximately 1.2 million people in the U.S. have calcified or otherwise damaged aortic valves, this large potential patient population will help drive the transcatheter heart valve replacement market....
Continue Reading →
Heart valve replacement procedures are a type of cardiac surgery. Generally, heart valve replacement is an open operation. However, recent advancements in technology has allowed for minimally invasive heart valve replacement procedures. ...
Continue Reading →
  • Left Atrial Appendage (LAA) Exclusion System
The new device offers an open-ended design combined with a tip-first closure mechanism to enable easier navigation and placement when operating in minimally-invasive surgery (MIS) environments....
Continue Reading →
  • Aortic vlalve corevalve evolut pro transcatheter
Introduction of New Pericardial Aortic Heart Valve in the U.S. and Europe Reinforces Company's Commitment to Comprehensive Solutions to Heart Valve Disease...
Continue Reading →
Unit sales are a primary driver of growth in the U.S. market for tissue heart valves; growth in these unit sales is powered by the continued shift in tissue valve procedure and material preference....
Continue Reading →
The number of radiofrequency catheters used in the United States is expected to increase steadily as more devices become FDA-approved for the treatment of A-Fib....
Continue Reading →

Thank you!

CLOSE

Login

Sign Up


Already have an account? Sign in

x